Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Review of the Literature
GLP-1 Agonists Show Promise in Treating Substance Use Disorders Nov 7, 2025 5 min read Updated: Dec 17, 2025 In recent years, medications originally developed to treat Type 2 diabetes, obesity, and other weight-related conditionssuch as semaglutide and liraglutideare showing promise in treating substance use disorders (SUDs)
We do not use one-size-fits-all protocols
These treatments are recommended alongside dietary adjustments and physical activity
2025 Discontinuing Glucagon-Like Peptide-1 Receptor Agonists and Body Habitus: A Systematic Review and Meta-Analysis
US$ 25.84
US$ 20.06
US$ 20.84
US$ 25.80
US$ 28.22
US$ 21.00
